期刊文献+

羟基多溴二苯醚生物活性的QSAR研究 被引量:3

QSAR Study on Bioactivity of Hydroxylated Polybrominated Diphenyl Ethers
下载PDF
导出
摘要 采用VSMP方法从大量的分子结构描述符中筛选最优子集,用多元线性回归方法分别构建了羟基多溴二苯醚(hydroxylated polybrominated diphenyl ethers,OH-PBDEs)对细胞色素CYP19介导类固醇生成的抑制活性,甲状腺受体-β(thyroid receptors,TR-β)的激素活性以及与甲状腺素结合球蛋白(thyrox-ine-binding globulin,TBG)和甲状腺转运蛋白(transthyretin,TTR)之间结合能力的定量构效关系(quantita-tive structure-activity relationship,QSAR)模型。模型的留一法交叉验证(leave-one-out cross validation,LOO-CV)相关系数Q2和拟合相关系数R2均高于0.95和0.97,表明模型具有良好的稳健性、拟合能力和预测能力。QSAR模型表明OH-PBDEs的分子三维结构和芳香性是其活性的重要影响因素。另外,分子中溴原子数量和取代位置对OH-PBDE生物活性具有重要影响。 Quantitative structure-activity relationship(QSAR)models are developed to predict the bioactivities of hydroxylated polybrominated diphenyl ethers(OH-PBDEs).The bioactivities are inhibition of steroidogenesis mediated by CYP19,hormone activity to thyroid receptor-β(TR-β),and binding interaction with thyroxine-binding globulin(TBG) and transthyretin(TTR).The VSMP(variable selection and modeling based on the prediction) technique is used to select optimal subset from large-size molecular descriptors.Multiple linear regression(MLR) method is employed to construct the QSAR models.The correlation coefficient of leave-one-out cross validation(Q2) and fitting correlation coefficient of models(R2) of four QSAR models are greater than 0.95 and 0.97 respectively.The statistics parameters show that overall models are robust and have good fitting and prediction for selecting bioactivities.The standard regression coefficients of models reveal that the 3D structure and aromaticity of OH-PBDEs are the most important factors for the bioactivities.In addition,the number and the position of bromine play an important role in the bioactivities of OH-PBDEs.
出处 《桂林理工大学学报》 CAS 北大核心 2011年第3期430-438,共9页 Journal of Guilin University of Technology
基金 广西自然科学基金项目(2011GXNSFA018061) 广西教育厅科研项目(200708LX265) 珍稀濒危动植物生态与环境保护省部共建教育部重点实验室研究基金(桂科能1002K001)
关键词 羟基多溴二苯醚(OH-PBDEs) 细胞色素CYP19 甲状腺受体-β(TR-β) 甲状腺素结合球蛋白(TBG) 甲状腺转运蛋白(TTR) hydroxylated polybrominated diphenyl ethers(OH-PBDEs) cytochrome CYP19 thyroid receptor-β(TR-β) thyroxine-binding globulin(TBG) transthyretin(TTR)
  • 相关文献

参考文献4

  • 1Hallgren S,Darnerud PO.Polybrominated diphenyl ethers (PBDEs) polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects. Toxicology . 2002
  • 2Cao J,,Lin Y,Guo L H, et al.Structure-based Investigation on the Binding Interaction of Hydroxylated Polybrominated Diphenyl Ethers with Thyroxine Transport Proteins. Toxicology . 2010
  • 3Todeschini,R,Consonni,V.Molecular Descriptors for Chemoinformatics. . 2009
  • 4Todeschini,R.,Consonni,V. Handbook of Molecular Descriptors . 2000

同被引文献35

  • 1Groves J T. Key elements of the chemistry of cytochrome P- 450: The oxygen rebound mechanism [ J ]. J. Chem. Edu., 1985, 62 (11): 928.
  • 2Lautraite S, Musonda A C, Doehmer J, et al. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1 [ J]. Mutagenesis, 2002, 17 (1): 45 -53.
  • 3Gooderham N J, Murray S, Lynch A M, et al. Heterocyclic amines : Evaluation of their role in diet associated human cancer[J]. British J. Clini. Pharm. , 1996, 42(1) : 91 -98.
  • 4Nebert D W, Dalton T P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis [J]. Nature Reviews Cancer, 2006, 6 (12) : 947 -960.
  • 5Hengstler J G, Van der Burg B, Steinberg P, et al. Interspecies differences in cancer susceptibility and toxicity [J]. Drug Metabolism Reviews, 1999, 31 (4) : 917 -970.
  • 6Shiroada T, Guengerich F P. Inhibition of human cytochroroe P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons [J]. Chem. Res. Toxic., 2006, 19 (2): 288- 294.
  • 7Tsuda H, Sekine K, Fujita K, et al. Cancer prevention by bovine lactoferrin and underlying mechanisms : A review of experimental and clinical studies [J]. Biochem. & Cell Biol. , 2002, 80 (1): 131-136.
  • 8Roy K, Roy P P. QSAR of cytochrome inhibitors [J]. Expert Opinion on Drug Metabolism & Toxicology, 2009, 5 (10) : 1245 -1266.
  • 9Karelson M, Lobanov V. Quantum-chemical descriptors in QSAR/QSPR studies [J]. Chem. Rev. , 1996, 96 (3) : 1027 - 1044.
  • 10LiuSS, LiuHL, YinCS, et al. VSMP: Anovelvariable selection and modeling method based on the prediction [J]. J. Chem. Inf. Comput. Sci., 2003, 43 (3), 964 - 969.

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部